News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,051 Results
Type
Article (14483)
Company Profile (282)
Press Release (254286)
Section
Business (79956)
Career Advice (200)
Deals (13321)
Drug Delivery (36)
Drug Development (50584)
Employer Resources (41)
FDA (5789)
Job Trends (5198)
News (145214)
Policy (10100)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (927)
Accelerated approval (2)
Adcomms (12)
Allergies (50)
Alliances (21818)
ALS (61)
Alzheimer's disease (838)
Antibody-drug conjugate (ADC) (88)
Approvals (5803)
Artificial intelligence (120)
Autoimmune disease (14)
Automation (5)
Bankruptcy (104)
Best Places to Work (4614)
BIOSECURE Act (5)
Biosimilars (40)
Biotechnology (232)
Bladder cancer (45)
Brain cancer (21)
Breast cancer (142)
Cancer (1323)
Cardiovascular disease (115)
Career advice (170)
Career pathing (2)
CAR-T (109)
Cell therapy (312)
Cervical cancer (8)
Clinical research (41023)
Collaboration (501)
Compensation (226)
Complete response letters (13)
COVID-19 (1044)
CRISPR (37)
C-suite (147)
Cystic fibrosis (76)
Data (1385)
Denatured (11)
Depression (29)
Diabetes (126)
Diagnostics (1342)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (81)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (83)
Earnings (29760)
Editorial (17)
Employer branding (5)
Employer resources (38)
Events (48377)
Executive appointments (412)
FDA (6418)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (474)
Gene editing (90)
Generative AI (9)
Gene therapy (235)
GLP-1 (361)
Government (1090)
Grass and pollen (2)
Guidances (18)
Healthcare (6709)
Huntington's disease (21)
IgA nephropathy (21)
Immunology and inflammation (81)
Indications (18)
Infectious disease (1107)
Inflammatory bowel disease (112)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (58)
Interviews (24)
IPO (7287)
IRA (11)
Job creations (879)
Job search strategy (162)
Kidney cancer (6)
Labor market (6)
Layoffs (203)
Leadership (2)
Legal (1392)
Liver cancer (30)
Lung cancer (188)
Lymphoma (84)
Machine learning (1)
Management (12)
Manufacturing (119)
MASH (49)
Medical device (2680)
Medtech (2681)
Mergers & acquisitions (6330)
Metabolic disorders (366)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (62)
Neuropsychiatric disorders (23)
Neuroscience (1215)
NextGen: Class of 2025 (2050)
Non-profit (893)
Northern California (1573)
Now hiring (21)
Obesity (186)
Opinion (108)
Ovarian cancer (60)
Pain (41)
Pancreatic cancer (52)
Parkinson's disease (110)
Partnered (8)
Patents (115)
Patient recruitment (67)
Peanut (36)
People (25661)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14463)
Phase II (19060)
Phase III (12108)
Pipeline (746)
Podcasts (47)
Policy (38)
Postmarket research (856)
Preclinical (6074)
Press Release (30)
Prostate cancer (55)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (279)
Real estate (1435)
Recruiting (17)
Regulatory (8627)
Reports (15)
Research institute (951)
Resumes & cover letters (25)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (56)
Series A (92)
Series B (60)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1395)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1987)
State (1)
Stomach cancer (5)
Supply chain (18)
Tariffs (3)
The Weekly (35)
United States (12322)
Vaccines (210)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (16)
Worklife (3)
Date
Today (67)
Last 7 days (450)
Last 30 days (1639)
Last 365 days (20117)
2025 (4960)
2024 (20729)
2023 (22571)
2022 (26979)
2021 (28013)
2020 (23579)
2019 (16446)
2018 (11893)
2017 (13848)
2016 (11957)
2015 (14478)
2014 (10474)
2013 (7560)
2012 (7589)
2011 (7690)
2010 (7486)
Location
Africa (156)
Alabama (38)
Alaska (2)
Arizona (55)
Arkansas (5)
Asia (17386)
Australia (2948)
California (3571)
Canada (1063)
China (327)
Colorado (140)
Connecticut (146)
Delaware (88)
Europe (37321)
Florida (423)
Georgia (110)
Idaho (17)
Illinois (214)
India (9)
Indiana (89)
Iowa (1)
Japan (71)
Kansas (60)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (447)
Massachusetts (2829)
Michigan (72)
Minnesota (138)
Mississippi (1)
Missouri (23)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (16)
New Jersey (900)
New Mexico (13)
New York (969)
North Carolina (528)
North Dakota (4)
Northern California (1573)
Ohio (110)
Oklahoma (9)
Oregon (21)
Pennsylvania (681)
Puerto Rico (3)
Rhode Island (15)
South America (217)
South Carolina (4)
Southern California (1395)
Tennessee (27)
Texas (414)
Utah (48)
Virginia (72)
Washington D.C. (28)
Washington State (323)
Wisconsin (13)
269,051 Results for "leap therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Leap Therapeutics Reports First Quarter 2024 Financial Results
Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported financial results for the first quarter ended March 31, 2024.
May 13, 2024
·
13 min read
Press Releases
Evinova and Quantum Leap Healthcare Partner to Incorporate Real-Time Remote Patient Monitoring into Breast Cancer Platform Trial
March 20, 2025
·
3 min read
Business
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported financial results for the fourth quarter and year ended December 31, 2023.
March 18, 2024
·
12 min read
Deals
Leap Therapeutics Announces $40 Million Private Placement
Leap Therapeutics, Inc. today announced it has entered into a securities purchase agreement with a select group of institutional investors to issue and sell an aggregate of 12,660,993 shares of its common stock (“Common Stock”) at a price of $2.82 per share and pre-funded warrants to purchase 1,523,404 shares of Common Stock at a price of $2.819 per share of Common Stock.
April 11, 2024
·
7 min read
Business
Leap Therapeutics Reports Third Quarter 2023 Financial Results
Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported financial results for the third quarter ended September 30, 2023.
November 13, 2023
·
10 min read
Press Releases
NIKKI’s Efficacy in Overcoming Lyme Disease to be Presented at 2024 Leap into Health Conference
December 13, 2024
·
5 min read
Press Releases
China Medical University and Healthcare System Pioneers AI-Driven Drug Discovery and Allogeneic CAR-T Therapy: A Groundbreaking Leap in Cancer Treatment
February 5, 2025
·
3 min read
Press Releases
Esphera SynBio Announces New Project to Advance Next Generation mRNA Vaccine Development, supported by the CQDM Quantum Leap program
January 10, 2025
·
2 min read
Genetown
Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
Leap Therapeutics, Inc. announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
January 3, 2024
·
1 min read
Genetown
Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference
Leap Therapeutics, Inc. today announced that Douglas E. Onsi , President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference in New York, NY.
November 21, 2023
·
1 min read
1 of 26,906
Next